Zhejiang Huakang Pharmaceutical Co., Ltd. (SHA:605077)
China
· Delayed Price · Currency is CNY 17.15
+0.07 (0.41%)
Apr 30, 2026, 11:30 AM CST
SHA:605077 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 5,066 | 4,384 | 4,385 | 5,077 | 6,931 | 6,829 | Upgrade
|
| Market Cap Growth | 12.04% | -0.03% | -13.63% | -26.76% | 1.50% | - | Upgrade
|
| Enterprise Value | 6,853 | 6,293 | 6,033 | 5,412 | 6,272 | 5,581 | Upgrade
|
| Last Close Price | 17.08 | 14.78 | 14.07 | 15.42 | 21.17 | 20.43 | Upgrade
|
| PE Ratio | 25.88 | 21.89 | 16.33 | 13.67 | 21.71 | 28.85 | Upgrade
|
| PS Ratio | 1.21 | 1.05 | 1.56 | 1.82 | 3.15 | 4.28 | Upgrade
|
| PB Ratio | 1.56 | 1.35 | 1.35 | 1.64 | 2.61 | 2.81 | Upgrade
|
| P/TBV Ratio | 1.95 | 1.69 | 1.69 | 2.06 | 2.90 | 2.95 | Upgrade
|
| P/OCF Ratio | 11.94 | 10.33 | 29.93 | 8.20 | 25.49 | 25.84 | Upgrade
|
| EV/Sales Ratio | 1.64 | 1.50 | 2.15 | 1.95 | 2.85 | 3.50 | Upgrade
|
| EV/EBITDA Ratio | 10.87 | 10.22 | 12.78 | 9.23 | 15.49 | 20.47 | Upgrade
|
| EV/EBIT Ratio | 21.20 | 19.47 | 22.11 | 13.09 | 20.95 | 29.66 | Upgrade
|
| Debt / Equity Ratio | 0.96 | 0.96 | 0.69 | 0.74 | 0.24 | 0.06 | Upgrade
|
| Debt / EBITDA Ratio | 4.97 | 4.97 | 4.73 | 3.90 | 1.59 | 0.52 | Upgrade
|
| Net Debt / Equity Ratio | 0.55 | 0.55 | 0.38 | -0.10 | -0.29 | -0.48 | Upgrade
|
| Net Debt / EBITDA Ratio | 2.88 | 2.88 | 2.59 | -0.52 | -1.93 | -4.30 | Upgrade
|
| Net Debt / FCF Ratio | -30.05 | -30.05 | -0.95 | 4.25 | 2.92 | 12.13 | Upgrade
|
| Asset Turnover | 0.56 | 0.56 | 0.43 | 0.55 | 0.64 | 0.72 | Upgrade
|
| Inventory Turnover | 4.86 | 4.86 | 4.49 | 7.52 | 7.09 | 6.99 | Upgrade
|
| Quick Ratio | 0.85 | 0.85 | 1.08 | 3.03 | 2.38 | 3.45 | Upgrade
|
| Current Ratio | 1.40 | 1.40 | 1.54 | 3.34 | 2.78 | 3.96 | Upgrade
|
| Return on Equity (ROE) | 6.23% | 6.23% | 8.46% | 12.94% | 12.54% | 14.03% | Upgrade
|
| Return on Assets (ROA) | 2.69% | 2.69% | 2.59% | 5.13% | 5.42% | 5.30% | Upgrade
|
| Return on Invested Capital (ROIC) | 5.72% | 6.10% | 7.03% | 15.60% | 17.78% | 16.64% | Upgrade
|
| Return on Capital Employed (ROCE) | 5.80% | 5.80% | 5.10% | 8.00% | 9.50% | 7.40% | Upgrade
|
| Earnings Yield | 3.95% | 4.57% | 6.12% | 7.32% | 4.61% | 3.47% | Upgrade
|
| FCF Yield | -1.16% | -1.34% | -29.26% | -1.40% | -3.86% | -1.42% | Upgrade
|
| Dividend Yield | 2.98% | - | 3.55% | 3.49% | 2.18% | 1.61% | Upgrade
|
| Payout Ratio | 126.54% | 126.54% | 73.21% | 46.60% | 35.06% | 50.84% | Upgrade
|
| Buyback Yield / Dilution | 19.74% | 19.74% | -27.25% | -0.23% | -3.09% | -28.98% | Upgrade
|
| Total Shareholder Return | 22.72% | 19.74% | -23.70% | 3.26% | -0.91% | -27.36% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.